Effect of desflurane at less than 1 MAC on QT interval prolongation induced by tracheal intubation

S H Kim1, S Y Park, W S Chae

  • 1Department of Anaesthesiology and Pain Medicine, College of Medicine, Soonchunhyang University, Bucheon Hospital, 1174 Jung-Dong, Wonmi-Gu, Bucheon-Si, Gyeonggi-Do, Republic of Korea. aurellius@naver.com

Abstract

Insights

Low-concentration desflurane (less than 1 minimum alveolar concentration) did not prolong the QT interval during tracheal intubation. This study found no significant difference in QTc prolongation between patients receiving desflurane and those receiving oxygen alone.

Area of Science:

  • Anesthesiology
  • Cardiology
  • Pharmacology

Background:

  • Desflurane at concentrations above 1 minimum alveolar concentration (MAC) is known to prolong the QT interval.
  • The effect of desflurane at sub-MAC concentrations on QT interval prolongation, particularly during tracheal intubation, remains unclear.

Purpose of the Study:

  • To investigate whether desflurane concentrations below 1 MAC influence the QT interval prolongation induced by tracheal intubation.

Main Methods:

  • A randomized controlled trial involving 44 subjects undergoing anesthesia induction with propofol.
  • Subjects received either 1 MAC desflurane in oxygen or oxygen alone prior to tracheal intubation.
  • QT intervals were corrected using Bazett's (QTcB) and Fridericia's (QTcF) formulae; secondary outcomes included Tp-e, mean arterial pressure (MAP), heart rate (HR), and bispectral index (BIS).

Main Results:

  • No significant difference in QTcB or QTcF was observed immediately after tracheal intubation between the desflurane and control groups.
  • Heart rate (HR) and the interval from peak to T wave end (Tp-e) did not differ between groups.
  • Mean arterial pressure (MAP) and bispectral index (BIS) scores were significantly lower in the desflurane group post-intubation.

Conclusions:

  • Administration of desflurane at 1 MAC during controlled ventilation does not exacerbate QT interval prolongation caused by tracheal intubation.
  • These findings suggest that desflurane at this concentration may be safely used in the context of tracheal intubation without adverse cardiac electrical effects.

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Endotracheal Intubation I: Procedure01:15

Endotracheal Intubation I: Procedure

Endotracheal or ET intubation is a critical medical procedure used to secure a patient's airway, often in acute respiratory distress, apnea, upper airway obstruction, ineffective clearance of secretions, high risk for aspiration, or during general anesthesia.
The ET tube comprises various components, including a standard adaptor to attach a bag-valve-mask (BVM) or ventilator, a cuff, a pilot balloon, and radiopaque markings along its length to measure the insertion distance. The tube sizes...
Endotracheal Tube Extubation01:24

Endotracheal Tube Extubation

Endotracheal tube extubation is a critical procedure in weaning patients from mechanical ventilation. It involves physically removing the oral or nasal endotracheal (ET) tube, marking the final step in liberating a patient from ventilatory support.
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals.
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.